Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.06 USD | +2.64% | +1.01% | +187.96% |
May. 08 | Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Treatment of Myotonic Dystrophy Type 1 | MT |
May. 08 | Avidity's Lead Program Gets FDA Breakthrough Designation | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+187.96% | 2.49B | |
-3.62% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+53.68% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-5.61% | 8.3B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences Insider Sold Shares Worth $1,691,306, According to a Recent SEC Filing